Phase Iii Clinical Trials in Oral Infectious Diseases

The summary for the Phase Iii Clinical Trials in Oral Infectious Diseases grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Phase Iii Clinical Trials in Oral Infectious Diseases: The National Institute of Dental and Craniofacial Research (NIDCR) encourages submission of investigator-initiated grant applications for Phase III clinical trials to assess the efficacy and safety of preventive or therapeutic interventions for oral infectious diseases. Such interventions should have high potential for translation into clinical practice and for improving the oral health status of all Americans. NIDCRs prior support for basic and clinical research has shown that dental caries, periodontal diseases, and many other oral diseases involve infectious processes that result from the interplay of infectious agents, environmental influences (e.g., diet), genetic factors, and host response. This initiative seeks to accelerate the translation of such findings into well-documented, cost- effective interventions of proven efficacy for preventing and treating oral infectious diseases. Clinical trials focusing on the periodontal diseases and dental caries are particularly encouraged given the uniquely prominent role that these disorders have in the delivery and cost of oral health care as well as their widespread prevalence in the population. However, clinical trials involving other oral conditions with an infectious cause bacterial, viral, or fungal will also be considered responsive to this PA. Applications that address novel interventions, higher risk population groups with oral health care disparities, research gaps, and common pathologic mechanisms are particularly encouraged.
Federal Grant Title: Phase Iii Clinical Trials in Oral Infectious Diseases
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-04-025
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.121
CFDA Descriptions: Oral Diseases and Disorders Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Nov 24, 2003
Creation Date: Nov 24, 2003
Archive Date: Dec 01, 2006
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workfo...
Epidemiological and Behavioral Research in Oral Health
Metagenomic Analyses of the Oral Microbiome
NIDCR Exploratory and Developmental Grants in Clinical Research
More Grants from the National Institutes of Health
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024